Foghorn Therapeutics Inc.
NASDAQ:FHTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
US |
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
B
|
BP PLC
F:BSU
|
UK |
|
C
|
China Construction Bank Corp
F:C6T
|
CN |
|
Fortress Biotech Inc
NASDAQ:FBIO
|
US |
|
B
|
Bloom Energy Corp
F:1ZB
|
US |
|
M
|
Mitsubishi Electric Corp
XMUN:MIE1
|
JP |
|
L
|
Lindblad Expeditions Holdings Inc
F:LI4
|
US |
|
H
|
Hyundai Motor Co
LSE:HYUP
|
KR |
|
BriQ Properties REIC
F:BRW
|
GR |
|
G
|
Grupo Aeroportuario del Sureste SAB de CV
SWB:AEDA
|
MX |
|
C
|
Comtech Telecommunications Corp
XMUN:CC6
|
US |
|
D
|
Dai-ichi Life Holdings Inc
XBER:QHH
|
JP |
|
N
|
Natera Inc
F:45E
|
US |
|
A
|
Asana Inc
F:A6N
|
US |
|
John Wiley & Sons Inc
NYSE:WLY
|
US |
|
A
|
Amerisafe Inc
F:A3I
|
US |
|
Z
|
Z Holdings Corp
OTC:YAHOF
|
JP |
|
B
|
Basf Se
MIL:BASF
|
DE |
|
M
|
Murphy Oil Corp
XMUN:MUQ
|
US |
|
J
|
Johnson Controls International PLC
F:TYIA
|
IE |
Bankruptcy Probability
Foghorn Therapeutics Inc.'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Foghorn Therapeutics Inc. Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
286.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
68.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Foghorn Therapeutics Inc.'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Foghorn Therapeutics Inc. has no debt.
You can find a full breakdown on its Balance Sheet.
